152 related articles for article (PubMed ID: 22662165)
1. Activation of β-catenin by oncogenic PIK3CA and EGFR promotes resistance to glucose deprivation by inducing a strong antioxidant response.
Cardone L; Bardelli A; Avvedimento VE
PLoS One; 2012; 7(5):e37526. PubMed ID: 22662165
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.
Higgins MJ; Beaver JA; Wong HY; Gustin JP; Lauring JD; Garay JP; Konishi H; Mohseni M; Wang GM; Cidado J; Jelovac D; Cosgrove DP; Tamaki A; Abukhdeir AM; Park BH
Cancer Biol Ther; 2011 Feb; 11(3):358-67. PubMed ID: 21124076
[TBL] [Abstract][Full Text] [Related]
3. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
4. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.
Young CD; Zimmerman LJ; Hoshino D; Formisano L; Hanker AB; Gatza ML; Morrison MM; Moore PD; Whitwell CA; Dave B; Stricker T; Bhola NE; Silva GO; Patel P; Brantley-Sieders DM; Levin M; Horiates M; Palma NA; Wang K; Stephens PJ; Perou CM; Weaver AM; O'Shaughnessy JA; Chang JC; Park BH; Liebler DC; Cook RS; Arteaga CL
Mol Cell Proteomics; 2015 Jul; 14(7):1959-76. PubMed ID: 25953087
[TBL] [Abstract][Full Text] [Related]
5. Knockin of mutant PIK3CA activates multiple oncogenic pathways.
Gustin JP; Karakas B; Weiss MB; Abukhdeir AM; Lauring J; Garay JP; Cosgrove D; Tamaki A; Konishi H; Konishi Y; Mohseni M; Wang G; Rosen DM; Denmeade SR; Higgins MJ; Vitolo MI; Bachman KE; Park BH
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2835-40. PubMed ID: 19196980
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
7. Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.
Eng J; Woo KM; Sima CS; Plodkowski A; Hellmann MD; Chaft JE; Kris MG; Arcila ME; Ladanyi M; Drilon A
J Thorac Oncol; 2015 Dec; 10(12):1713-9. PubMed ID: 26334752
[TBL] [Abstract][Full Text] [Related]
8. KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.
Messner I; Cadeddu G; Huckenbeck W; Knowles HJ; Gabbert HE; Baldus SE; Schaefer KL
J Cancer Res Clin Oncol; 2013 Feb; 139(2):201-9. PubMed ID: 23015072
[TBL] [Abstract][Full Text] [Related]
9. Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the
Jiang W; Wu Y; He T; Zhu H; Ke G; Xiang L; Yang H
Mol Cancer Ther; 2020 Feb; 19(2):337-347. PubMed ID: 31666350
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.
Jhawer M; Goel S; Wilson AJ; Montagna C; Ling YH; Byun DS; Nasser S; Arango D; Shin J; Klampfer L; Augenlicht LH; Perez-Soler R; Mariadason JM
Cancer Res; 2008 Mar; 68(6):1953-61. PubMed ID: 18339877
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.
Lee CH; Hung HW; Hung PH; Shieh YS
Mol Cancer; 2010 Mar; 9():64. PubMed ID: 20302655
[TBL] [Abstract][Full Text] [Related]
13. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.
Kwon IK; Wang R; Thangaraju M; Shuang H; Liu K; Dashwood R; Dulin N; Ganapathy V; Browning DD
Oncogene; 2010 Jun; 29(23):3423-34. PubMed ID: 20348951
[TBL] [Abstract][Full Text] [Related]
14. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells.
Guturi KK; Mandal T; Chatterjee A; Sarkar M; Bhattacharya S; Chatterjee U; Ghosh MK
J Biol Chem; 2012 May; 287(22):18287-96. PubMed ID: 22493441
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.
Schafer ZT; Grassian AR; Song L; Jiang Z; Gerhart-Hines Z; Irie HY; Gao S; Puigserver P; Brugge JS
Nature; 2009 Sep; 461(7260):109-13. PubMed ID: 19693011
[TBL] [Abstract][Full Text] [Related]
17. Glucose deprivation triggers protein kinase C-dependent β-catenin proteasomal degradation.
Choi SW; Song JK; Yim YS; Yun HG; Chun KH
J Biol Chem; 2015 Apr; 290(15):9863-73. PubMed ID: 25691573
[TBL] [Abstract][Full Text] [Related]
18. Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.
de Vries M; Bruijn IB; Cleton-Jansen AM; Malessy MJ; van der Mey AG; Hogendoorn PC
Virchows Arch; 2013 Feb; 462(2):211-7. PubMed ID: 23224067
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative effects of ethyl 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate against amyloid β-induced oxidative cell death via NF-κB, GSK-3β and β-catenin signaling pathways in cultured cortical neurons.
Kim EA; Cho CH; Kim DW; Choi SY; Huh JW; Cho SW
Free Radic Res; 2015 Apr; 49(4):411-21. PubMed ID: 25747393
[TBL] [Abstract][Full Text] [Related]
20. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
